Target price | $15.50 |
Course | $1.21 |
Price potential |
1,180.99%
register free of charge
|
Number of estimates | 2 |
2 Analysts have issued a price target Inhibikase Therapeutics Inc 2025 .
The average Inhibikase Therapeutics Inc target price is $15.50.
This is
1,180.99%
register free of charge
$23.00
1,800.83%
register free of charge
$8.00
561.16%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Inhibikase Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst estimates: Analysts believe that the Inhibikase Therapeutics Inc share has an average upside potential 2025 of
1,180.99%
register free of charge
|
Dec '23 |
2024 Forecast |
|
---|---|---|
Earnings per share $ | -3.57 | -2.33 |
16.98% | 34.73% | |
P/E ratio | negative |
1 Analysts have issued a Inhibikase Therapeutics Inc forecast for earnings per share. The average Inhibikase Therapeutics Inc <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Inhibikase Therapeutics Inc...
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.